The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kompella Lopa Mudra
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kompella Lopa Mudra, part of the promoter group of Vivo Bio Tech Limited, received an allotment of 90,000 equity shares on January 06, 2026, following the conversion of warrants that had earlier been issued on a preferential basis. Her direct shareholding with voting rights rose from 2,43,333 shares (1.10%) to 3,33,000 shares (1.50%), while encumbered shares fell correspondingly from 4,40,000 to 3,50,000. Her total holding in the company remained unchanged at 6,83,333 shares, equal to 3.09% of the equity capital. The company's total share count moved marginally from 2,21,00,628 to 2,21,90,628 equity shares of Rs 10 each as a result of this and similar conversions.
There is no change in overall promoter group stake (3.09%); the transaction simply reclassifies 90,000 shares from encumbered warrants to freely voting equity, marginally boosting direct voting rights while reducing encumbrance – neutral to mildly positive for share liquidity perception.